0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Biologics Targeting CCR4 Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-37J15650
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Biologics Targeting CCR4 Market Research Report 2023
BUY CHAPTERS

Global Biologics Targeting CCR4 Market Research Report 2025

Code: QYRE-Auto-37J15650
Report
May 2025
Pages:74
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Biologics Targeting CCR4 Market

The global market for Biologics Targeting CCR4 was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
CCR4-targeted biologics are biologics used to treat specific diseases that inhibit or modulate the function of the CCR4 receptor. CCR4 is a cell surface receptor in the immune system that is often associated with regulating immune responses and cell movement. Such biologics are often designed to address abnormal CCR4 activity in certain diseases, particularly those involving the immune system. Among them, one of the most common application areas is the treatment of malignant lymphomas, especially T-cell lymphomas, such as lobectomy cell lymphoma and cutaneous T-cell lymphoma. CCR4 biologics can help inhibit tumor growth by interfering with CCR4 receptor signaling and limiting the proliferation and spread of malignant T cells.
North American market for Biologics Targeting CCR4 is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Biologics Targeting CCR4 is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Biologics Targeting CCR4 include Kyowa, RAPT Therapeutics, Inc, Hanmi Pharmaceutical Co., Ltd, Eight Plus One Pharmaceutical Co Ltd, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Biologics Targeting CCR4, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologics Targeting CCR4.
The Biologics Targeting CCR4 market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biologics Targeting CCR4 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biologics Targeting CCR4 manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Biologics Targeting CCR4 Market Report

Report Metric Details
Report Name Biologics Targeting CCR4 Market
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Kyowa, RAPT Therapeutics, Inc, Hanmi Pharmaceutical Co., Ltd, Eight Plus One Pharmaceutical Co Ltd
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Biologics Targeting CCR4 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Biologics Targeting CCR4 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Biologics Targeting CCR4 Market report?

Ans: The main players in the Biologics Targeting CCR4 Market are Kyowa, RAPT Therapeutics, Inc, Hanmi Pharmaceutical Co., Ltd, Eight Plus One Pharmaceutical Co Ltd

What are the Application segmentation covered in the Biologics Targeting CCR4 Market report?

Ans: The Applications covered in the Biologics Targeting CCR4 Market report are Sézary Syndrome, Mycosis Fungoides

What are the Type segmentation covered in the Biologics Targeting CCR4 Market report?

Ans: The Types covered in the Biologics Targeting CCR4 Market report are Monoclonal Antibodies, Small Molecule Chemicals

Recommended Reports

Cancer Therapy Markets

Cell & Immunotherapy

Lymphoma & Leukemia

1 Biologics Targeting CCR4 Market Overview
1.1 Product Definition
1.2 Biologics Targeting CCR4 by Type
1.2.1 Global Biologics Targeting CCR4 Market Value Comparison by Type (2024 VS 2031)
1.2.2 Monoclonal Antibodies
1.2.3 Small Molecule Chemicals
1.3 Biologics Targeting CCR4 by Application
1.3.1 Global Biologics Targeting CCR4 Market Value by Application (2024 VS 2031)
1.3.2 Sézary Syndrome
1.3.3 Mycosis Fungoides
1.4 Global Biologics Targeting CCR4 Market Size Estimates and Forecasts
1.4.1 Global Biologics Targeting CCR4 Revenue 2020-2031
1.4.2 Global Biologics Targeting CCR4 Sales 2020-2031
1.4.3 Global Biologics Targeting CCR4 Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Biologics Targeting CCR4 Market Competition by Manufacturers
2.1 Global Biologics Targeting CCR4 Sales Market Share by Manufacturers (2020-2025)
2.2 Global Biologics Targeting CCR4 Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Biologics Targeting CCR4 Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Biologics Targeting CCR4, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Biologics Targeting CCR4, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Biologics Targeting CCR4, Product Type & Application
2.7 Global Key Manufacturers of Biologics Targeting CCR4, Date of Enter into This Industry
2.8 Global Biologics Targeting CCR4 Market Competitive Situation and Trends
2.8.1 Global Biologics Targeting CCR4 Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Biologics Targeting CCR4 Players Market Share by Revenue
2.8.3 Global Biologics Targeting CCR4 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Biologics Targeting CCR4 Market Scenario by Region
3.1 Global Biologics Targeting CCR4 Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Biologics Targeting CCR4 Sales by Region: 2020-2031
3.2.1 Global Biologics Targeting CCR4 Sales by Region: 2020-2025
3.2.2 Global Biologics Targeting CCR4 Sales by Region: 2026-2031
3.3 Global Biologics Targeting CCR4 Revenue by Region: 2020-2031
3.3.1 Global Biologics Targeting CCR4 Revenue by Region: 2020-2025
3.3.2 Global Biologics Targeting CCR4 Revenue by Region: 2026-2031
3.4 North America Biologics Targeting CCR4 Market Facts & Figures by Country
3.4.1 North America Biologics Targeting CCR4 Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Biologics Targeting CCR4 Sales by Country (2020-2031)
3.4.3 North America Biologics Targeting CCR4 Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Biologics Targeting CCR4 Market Facts & Figures by Country
3.5.1 Europe Biologics Targeting CCR4 Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Biologics Targeting CCR4 Sales by Country (2020-2031)
3.5.3 Europe Biologics Targeting CCR4 Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Biologics Targeting CCR4 Market Facts & Figures by Region
3.6.1 Asia Pacific Biologics Targeting CCR4 Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Biologics Targeting CCR4 Sales by Region (2020-2031)
3.6.3 Asia Pacific Biologics Targeting CCR4 Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Biologics Targeting CCR4 Market Facts & Figures by Country
3.7.1 Latin America Biologics Targeting CCR4 Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Biologics Targeting CCR4 Sales by Country (2020-2031)
3.7.3 Latin America Biologics Targeting CCR4 Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Biologics Targeting CCR4 Market Facts & Figures by Country
3.8.1 Middle East and Africa Biologics Targeting CCR4 Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Biologics Targeting CCR4 Sales by Country (2020-2031)
3.8.3 Middle East and Africa Biologics Targeting CCR4 Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Biologics Targeting CCR4 Sales by Type (2020-2031)
4.1.1 Global Biologics Targeting CCR4 Sales by Type (2020-2025)
4.1.2 Global Biologics Targeting CCR4 Sales by Type (2026-2031)
4.1.3 Global Biologics Targeting CCR4 Sales Market Share by Type (2020-2031)
4.2 Global Biologics Targeting CCR4 Revenue by Type (2020-2031)
4.2.1 Global Biologics Targeting CCR4 Revenue by Type (2020-2025)
4.2.2 Global Biologics Targeting CCR4 Revenue by Type (2026-2031)
4.2.3 Global Biologics Targeting CCR4 Revenue Market Share by Type (2020-2031)
4.3 Global Biologics Targeting CCR4 Price by Type (2020-2031)
5 Segment by Application
5.1 Global Biologics Targeting CCR4 Sales by Application (2020-2031)
5.1.1 Global Biologics Targeting CCR4 Sales by Application (2020-2025)
5.1.2 Global Biologics Targeting CCR4 Sales by Application (2026-2031)
5.1.3 Global Biologics Targeting CCR4 Sales Market Share by Application (2020-2031)
5.2 Global Biologics Targeting CCR4 Revenue by Application (2020-2031)
5.2.1 Global Biologics Targeting CCR4 Revenue by Application (2020-2025)
5.2.2 Global Biologics Targeting CCR4 Revenue by Application (2026-2031)
5.2.3 Global Biologics Targeting CCR4 Revenue Market Share by Application (2020-2031)
5.3 Global Biologics Targeting CCR4 Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Kyowa
6.1.1 Kyowa Company Information
6.1.2 Kyowa Description and Business Overview
6.1.3 Kyowa Biologics Targeting CCR4 Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Kyowa Biologics Targeting CCR4 Product Portfolio
6.1.5 Kyowa Recent Developments/Updates
6.2 RAPT Therapeutics, Inc
6.2.1 RAPT Therapeutics, Inc Company Information
6.2.2 RAPT Therapeutics, Inc Description and Business Overview
6.2.3 RAPT Therapeutics, Inc Biologics Targeting CCR4 Sales, Revenue and Gross Margin (2020-2025)
6.2.4 RAPT Therapeutics, Inc Biologics Targeting CCR4 Product Portfolio
6.2.5 RAPT Therapeutics, Inc Recent Developments/Updates
6.3 Hanmi Pharmaceutical Co., Ltd
6.3.1 Hanmi Pharmaceutical Co., Ltd Company Information
6.3.2 Hanmi Pharmaceutical Co., Ltd Description and Business Overview
6.3.3 Hanmi Pharmaceutical Co., Ltd Biologics Targeting CCR4 Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Hanmi Pharmaceutical Co., Ltd Biologics Targeting CCR4 Product Portfolio
6.3.5 Hanmi Pharmaceutical Co., Ltd Recent Developments/Updates
6.4 Eight Plus One Pharmaceutical Co Ltd
6.4.1 Eight Plus One Pharmaceutical Co Ltd Company Information
6.4.2 Eight Plus One Pharmaceutical Co Ltd Description and Business Overview
6.4.3 Eight Plus One Pharmaceutical Co Ltd Biologics Targeting CCR4 Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Eight Plus One Pharmaceutical Co Ltd Biologics Targeting CCR4 Product Portfolio
6.4.5 Eight Plus One Pharmaceutical Co Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Biologics Targeting CCR4 Industry Chain Analysis
7.2 Biologics Targeting CCR4 Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Biologics Targeting CCR4 Production Mode & Process Analysis
7.4 Biologics Targeting CCR4 Sales and Marketing
7.4.1 Biologics Targeting CCR4 Sales Channels
7.4.2 Biologics Targeting CCR4 Distributors
7.5 Biologics Targeting CCR4 Customer Analysis
8 Biologics Targeting CCR4 Market Dynamics
8.1 Biologics Targeting CCR4 Industry Trends
8.2 Biologics Targeting CCR4 Market Drivers
8.3 Biologics Targeting CCR4 Market Challenges
8.4 Biologics Targeting CCR4 Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Biologics Targeting CCR4 Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Biologics Targeting CCR4 Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Biologics Targeting CCR4 Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Biologics Targeting CCR4 Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Biologics Targeting CCR4 Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Biologics Targeting CCR4 Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Biologics Targeting CCR4 Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Biologics Targeting CCR4 Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Biologics Targeting CCR4, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Biologics Targeting CCR4, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Biologics Targeting CCR4, Product Type & Application
 Table 12. Global Key Manufacturers of Biologics Targeting CCR4, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Biologics Targeting CCR4 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics Targeting CCR4 as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Biologics Targeting CCR4 Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Biologics Targeting CCR4 Sales by Region (2020-2025) & (K Units)
 Table 18. Global Biologics Targeting CCR4 Sales Market Share by Region (2020-2025)
 Table 19. Global Biologics Targeting CCR4 Sales by Region (2026-2031) & (K Units)
 Table 20. Global Biologics Targeting CCR4 Sales Market Share by Region (2026-2031)
 Table 21. Global Biologics Targeting CCR4 Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Biologics Targeting CCR4 Revenue Market Share by Region (2020-2025)
 Table 23. Global Biologics Targeting CCR4 Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Biologics Targeting CCR4 Revenue Market Share by Region (2026-2031)
 Table 25. North America Biologics Targeting CCR4 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Biologics Targeting CCR4 Sales by Country (2020-2025) & (K Units)
 Table 27. North America Biologics Targeting CCR4 Sales by Country (2026-2031) & (K Units)
 Table 28. North America Biologics Targeting CCR4 Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Biologics Targeting CCR4 Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Biologics Targeting CCR4 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Biologics Targeting CCR4 Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Biologics Targeting CCR4 Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Biologics Targeting CCR4 Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Biologics Targeting CCR4 Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Biologics Targeting CCR4 Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Biologics Targeting CCR4 Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Biologics Targeting CCR4 Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Biologics Targeting CCR4 Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Biologics Targeting CCR4 Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Biologics Targeting CCR4 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Biologics Targeting CCR4 Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Biologics Targeting CCR4 Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Biologics Targeting CCR4 Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Biologics Targeting CCR4 Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Biologics Targeting CCR4 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Biologics Targeting CCR4 Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Biologics Targeting CCR4 Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Biologics Targeting CCR4 Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Biologics Targeting CCR4 Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Biologics Targeting CCR4 Sales (K Units) by Type (2020-2025)
 Table 51. Global Biologics Targeting CCR4 Sales (K Units) by Type (2026-2031)
 Table 52. Global Biologics Targeting CCR4 Sales Market Share by Type (2020-2025)
 Table 53. Global Biologics Targeting CCR4 Sales Market Share by Type (2026-2031)
 Table 54. Global Biologics Targeting CCR4 Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Biologics Targeting CCR4 Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Biologics Targeting CCR4 Revenue Market Share by Type (2020-2025)
 Table 57. Global Biologics Targeting CCR4 Revenue Market Share by Type (2026-2031)
 Table 58. Global Biologics Targeting CCR4 Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Biologics Targeting CCR4 Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Biologics Targeting CCR4 Sales (K Units) by Application (2020-2025)
 Table 61. Global Biologics Targeting CCR4 Sales (K Units) by Application (2026-2031)
 Table 62. Global Biologics Targeting CCR4 Sales Market Share by Application (2020-2025)
 Table 63. Global Biologics Targeting CCR4 Sales Market Share by Application (2026-2031)
 Table 64. Global Biologics Targeting CCR4 Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Biologics Targeting CCR4 Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Biologics Targeting CCR4 Revenue Market Share by Application (2020-2025)
 Table 67. Global Biologics Targeting CCR4 Revenue Market Share by Application (2026-2031)
 Table 68. Global Biologics Targeting CCR4 Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Biologics Targeting CCR4 Price (US$/Unit) by Application (2026-2031)
 Table 70. Kyowa Company Information
 Table 71. Kyowa Description and Business Overview
 Table 72. Kyowa Biologics Targeting CCR4 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Kyowa Biologics Targeting CCR4 Product
 Table 74. Kyowa Recent Developments/Updates
 Table 75. RAPT Therapeutics, Inc Company Information
 Table 76. RAPT Therapeutics, Inc Description and Business Overview
 Table 77. RAPT Therapeutics, Inc Biologics Targeting CCR4 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. RAPT Therapeutics, Inc Biologics Targeting CCR4 Product
 Table 79. RAPT Therapeutics, Inc Recent Developments/Updates
 Table 80. Hanmi Pharmaceutical Co., Ltd Company Information
 Table 81. Hanmi Pharmaceutical Co., Ltd Description and Business Overview
 Table 82. Hanmi Pharmaceutical Co., Ltd Biologics Targeting CCR4 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Hanmi Pharmaceutical Co., Ltd Biologics Targeting CCR4 Product
 Table 84. Hanmi Pharmaceutical Co., Ltd Recent Developments/Updates
 Table 85. Eight Plus One Pharmaceutical Co Ltd Company Information
 Table 86. Eight Plus One Pharmaceutical Co Ltd Description and Business Overview
 Table 87. Eight Plus One Pharmaceutical Co Ltd Biologics Targeting CCR4 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Eight Plus One Pharmaceutical Co Ltd Biologics Targeting CCR4 Product
 Table 89. Eight Plus One Pharmaceutical Co Ltd Recent Developments/Updates
 Table 90. Key Raw Materials Lists
 Table 91. Raw Materials Key Suppliers Lists
 Table 92. Biologics Targeting CCR4 Distributors List
 Table 93. Biologics Targeting CCR4 Customers List
 Table 94. Biologics Targeting CCR4 Market Trends
 Table 95. Biologics Targeting CCR4 Market Drivers
 Table 96. Biologics Targeting CCR4 Market Challenges
 Table 97. Biologics Targeting CCR4 Market Restraints
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources
 Table 101. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Biologics Targeting CCR4
 Figure 2. Global Biologics Targeting CCR4 Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Biologics Targeting CCR4 Market Share by Type: 2024 & 2031
 Figure 4. Monoclonal Antibodies Product Picture
 Figure 5. Small Molecule Chemicals Product Picture
 Figure 6. Global Biologics Targeting CCR4 Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Biologics Targeting CCR4 Market Share by Application: 2024 & 2031
 Figure 8. Sézary Syndrome
 Figure 9. Mycosis Fungoides
 Figure 10. Global Biologics Targeting CCR4 Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Biologics Targeting CCR4 Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Biologics Targeting CCR4 Sales (2020-2031) & (K Units)
 Figure 13. Global Biologics Targeting CCR4 Average Price (US$/Unit) & (2020-2031)
 Figure 14. Biologics Targeting CCR4 Report Years Considered
 Figure 15. Biologics Targeting CCR4 Sales Share by Manufacturers in 2024
 Figure 16. Global Biologics Targeting CCR4 Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Biologics Targeting CCR4 Players: Market Share by Revenue in Biologics Targeting CCR4 in 2024
 Figure 18. Biologics Targeting CCR4 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Biologics Targeting CCR4 Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Biologics Targeting CCR4 Sales Market Share by Country (2020-2031)
 Figure 21. North America Biologics Targeting CCR4 Revenue Market Share by Country (2020-2031)
 Figure 22. United States Biologics Targeting CCR4 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Biologics Targeting CCR4 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Biologics Targeting CCR4 Sales Market Share by Country (2020-2031)
 Figure 25. Europe Biologics Targeting CCR4 Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Biologics Targeting CCR4 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Biologics Targeting CCR4 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Biologics Targeting CCR4 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Biologics Targeting CCR4 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Biologics Targeting CCR4 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Biologics Targeting CCR4 Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Biologics Targeting CCR4 Revenue Market Share by Region (2020-2031)
 Figure 33. China Biologics Targeting CCR4 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Biologics Targeting CCR4 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Biologics Targeting CCR4 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Biologics Targeting CCR4 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Biologics Targeting CCR4 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Biologics Targeting CCR4 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Biologics Targeting CCR4 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America Biologics Targeting CCR4 Sales Market Share by Country (2020-2031)
 Figure 41. Latin America Biologics Targeting CCR4 Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico Biologics Targeting CCR4 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil Biologics Targeting CCR4 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina Biologics Targeting CCR4 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Middle East and Africa Biologics Targeting CCR4 Sales Market Share by Country (2020-2031)
 Figure 46. Middle East and Africa Biologics Targeting CCR4 Revenue Market Share by Country (2020-2031)
 Figure 47. Turkey Biologics Targeting CCR4 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Biologics Targeting CCR4 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. UAE Biologics Targeting CCR4 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Global Sales Market Share of Biologics Targeting CCR4 by Type (2020-2031)
 Figure 51. Global Revenue Market Share of Biologics Targeting CCR4 by Type (2020-2031)
 Figure 52. Global Biologics Targeting CCR4 Price (US$/Unit) by Type (2020-2031)
 Figure 53. Global Sales Market Share of Biologics Targeting CCR4 by Application (2020-2031)
 Figure 54. Global Revenue Market Share of Biologics Targeting CCR4 by Application (2020-2031)
 Figure 55. Global Biologics Targeting CCR4 Price (US$/Unit) by Application (2020-2031)
 Figure 56. Biologics Targeting CCR4 Value Chain
 Figure 57. Channels of Distribution (Direct Vs Distribution)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners